Adiponectin, IGFBP-1 and -2 are independent predictors in forecasting prediabetes and type 2 diabetes

An Insulin Resistance Score Improved Diabetes Risk Assessment in the Malmö Prevention Project—A Longitudinal Population-Based Study of Older Europeans

(2021) Dov Shiffman et al.   DIABETES CARE

Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer

(2021) Joseph A. M. J. L. Janssen   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Development of a novel assay for IGFBP-2 complexed with IGF-I and-II in human serum

(2020) Jonas Agerholm et al.   GROWTH HORMONE & IGF RESEARCH

A Panel of 6 Biomarkers Significantly Improves the Prediction of Type 2 Diabetes in the MONICA/KORA Study Population

(2020) Barbara Thorand et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives

(2019) Hidekatsu Yanai et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease

(2019) Torgny Karlsson et al.   NATURE MEDICINE

Role of IGF-binding proteins in regulating IGF responses to changes in metabolism

(2018) David R Clemmons   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis

(2018) Yeli Wang et al.   Scientific Reports

Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes

(2018) Clemens Wittenbecher et al.   DIABETES

The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes

(2018) Natalie J. Haywood et al.   Molecular Metabolism

Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor–Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC–Potsdam Study

(2016) Dagmar Drogan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Insulin-Like Growth Factor Axis and Gestational Diabetes Mellitus: A Longitudinal Study in a Multiracial Cohort

(2016) Yeyi Zhu et al.   DIABETES

Omentin-1, Adiponectin, and the Risk of Developing Type 2 Diabetes: Table 1

(2016) Clemens Wittenbecher et al.   DIABETES CARE

IGFBP1 increases β‐cell regeneration by promoting α‐ to β‐cell transdifferentiation

(2016) Jing Lu et al.   EMBO JOURNAL

Physiology and pathophysiology of IGFBP-1 and IGFBP-2 – Consensus and dissent on metabolic control and malignant potential

(2015) Andreas Hoeflich et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

IGFBP-2 - taking the lead in growth, metabolism and cancer

(2015) Steven W. Yau et al.   Journal of Cell Communication and Signaling

Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides

(2014) Sophie Carter et al.   ATHEROSCLEROSIS

Insulin-like growth factor-II: its role in metabolic and endocrine disease

(2014) Callum Livingstone et al.   CLINICAL ENDOCRINOLOGY

Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in women

(2014) Jeannette M. Beasley et al.   GROWTH HORMONE & IGF RESEARCH

Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes

(2013) Rikke Hjortebjerg et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Leptin and adiponectin: Distribution and associations with cardiovascular risk factors in men and women of the general population

(2012) Anna Nixon Andreasson et al.   AMERICAN JOURNAL OF HUMAN BIOLOGY

Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women

(2012) S. N. Rajpathak et al.   DIABETES

The Insulin-Like Growth Factor System, Metabolic Syndrome, and Cardiovascular Disease Risk

(2011) Abayomi O Akanji et al.   Metabolic Syndrome and Related Disorders

Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene

(2010) Kristina Hedbacker et al.   Cell Metabolism

IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women

(2010) Moira S Lewitt et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prediction of incident diabetes mellitus by baseline IGF1 levels

(2010) Harald Jörn Schneider et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): The Söderåkra Cardiovascular Risk Factor Study

(2009) U. Petersson et al.   DIABETES & METABOLISM

Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes

(2009) Juha Saltevo et al.   Gender Medicine

IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

(2009) Stephen B. Wheatcroft et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Psychological distress and risk of pre-diabetes and Type2 diabetes in a prospective study of Swedish middle-aged men and women

(2008) A.-K. Eriksson et al.   DIABETIC MEDICINE

Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men

(2008) M. S. Lewitt et al.   DIABETOLOGIA

Insulin-Like Growth Factor Binding Protein 1 as a Novel Specific Marker of Hepatic Insulin Sensitivity

(2008) Anna Kotronen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM